Last Updated : May 29, 2019
Details
Generic Name:
decitabine
Project Status:
Not filed
Therapeutic Area:
Myelodysplastic Syndromes
Manufacturer:
Pharmascience Inc.
Brand Name:
Demylocan
Project Line:
Reimbursement Review
Project Number:
NS0001-000
Submission Type:
Non Submission
Fee Schedule:
N/A
Indications:
Myelodysplastic Syndromes
Sponsor:
Recommendation Type:
Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission.
Last Updated : May 29, 2019